ERBB2 and cancer: The imaging setting investigated is that of the mouse biodistribution of the single-domain antibody fragment (sdAb) 2Rs15d radiolabelled with 131I, a radioligand previously reported and described in [15] which is currently being tested in humans for targeted radionuclide therapy of HER2-expressing cancer [16].